Resources
Filter by Topic
- Blogs
As the demands on real-world data teams continue to grow, with more data sources, more stakeholders, and more pressure to deliver trusted evidence faster, the...
- Blogs
Health economics and outcomes research (HEOR), epidemiology, and real-world evidence (RWE) teams are under growing pressure to deliver meaningful insights faster than ever before. As...
- Blogs
Learn what organizations must do to balance speed, transparency, governance, and innovation in an increasingly data-driven and AI-reliant environment.
- Blogs
By Stacy Justo, Meghana Shamsunder, and Marten van den Berg
- Blogs
As regulators around the world grow more comfortable with real-world data (RWD) and AI-enabled evidence generation, pharma companies are rethinking how, and when, they build...
- Blogs
As real-world data (RWD) becomes more central to healthcare decision making, evidence generation is playing an increasingly important role, from early identification to treatment optimization...
- Press Releases
Embed validated patient phenotype definitions directly into your workflow for faster insights
Validation of Obesity Coding Among Newly Treated Nonvalvular Atrial Fibrillation Patient Using an Integrated Electronic Medical Record and Claims Database
Authors: R Jain, A Watzker, X Luo, A Kang, C Baker Published: Current Medical Research and Opinion Click here for the article.
Economic Burden of Treatment Resistant Depression on the US Health Care System
Authors: M Sussman, A O’Sullivan, A Shah, M Olfson, J Menzin Published: Journal of Managed Care and Specialty Pharmacy Click here to view the article.
Temporal trends in treatment and survival of older adult diffuse large B-Cell lymphoma patients in the SEER-Medicare linked database
Authors: J Shaw, C Harvey, C Richards, C Kim Published: Leukemia and Lymphoma Click here for the article.
Changes over time in treatment among patients with Rheumatoid Arthritis (RA) in Japan: Evidence from JMDC Inc. Database
Authors: L Zhang, R Jain, C Richards, J Menzin Published: Value in Health, ISPOR 2019 Click here for the article.
BHE Secures $78 Million in Growth Funding Led by Silversmith Capital Partners and LTP [Press Release]
BHE, an innovative healthcare analytics company, today announced a $78 million minority growth investment led by Silversmith Capital Partners (“Silversmith”) and Leerink Transformation Partners (“LTP”).
Announcing Ready Access to OM1 Registry Databases via BHE’s Instant Health Data (IHD) Platform [Press Release]
BHE is pleased to announce a new partnership with OM1 that facilitates the direct licensing of, and access to, OM1’s Disease Registry Databases via BHE’s
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization